MX9800603A - Uso de la ipriflavona para reducir el numero de celulas cd8+. - Google Patents
Uso de la ipriflavona para reducir el numero de celulas cd8+.Info
- Publication number
- MX9800603A MX9800603A MX9800603A MX9800603A MX9800603A MX 9800603 A MX9800603 A MX 9800603A MX 9800603 A MX9800603 A MX 9800603A MX 9800603 A MX9800603 A MX 9800603A MX 9800603 A MX9800603 A MX 9800603A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- pharmaceutical compositions
- ipriflavone
- reduce
- isopropoxyisoflavone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP9502198 | 1995-07-21 | ||
| HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
| PCT/HU1996/000038 WO1997003664A1 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA98000603A MXPA98000603A (en) | 1998-04-01 |
| MX9800603A true MX9800603A (es) | 1998-04-30 |
Family
ID=10987063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9800603A MX9800603A (es) | 1995-07-21 | 1996-07-16 | Uso de la ipriflavona para reducir el numero de celulas cd8+. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0841915A1 (cs) |
| JP (1) | JP2001503371A (cs) |
| KR (1) | KR19990028933A (cs) |
| CN (1) | CN1191483A (cs) |
| AR (1) | AR002905A1 (cs) |
| AU (1) | AU6367096A (cs) |
| BG (1) | BG102182A (cs) |
| BR (1) | BR9610187A (cs) |
| CA (1) | CA2227421A1 (cs) |
| CZ (1) | CZ2798A3 (cs) |
| EA (1) | EA199800146A1 (cs) |
| EE (1) | EE9800020A (cs) |
| HR (1) | HRP960345A2 (cs) |
| HU (1) | HU9502198D0 (cs) |
| IL (1) | IL122751A0 (cs) |
| MX (1) | MX9800603A (cs) |
| NO (1) | NO980127D0 (cs) |
| PL (1) | PL324460A1 (cs) |
| SK (1) | SK3298A3 (cs) |
| WO (1) | WO1997003664A1 (cs) |
| YU (1) | YU42796A (cs) |
| ZA (1) | ZA966079B (cs) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241079B (it) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/hu unknown
-
1996
- 1996-07-16 PL PL96324460A patent/PL324460A1/xx unknown
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 CN CN96195722A patent/CN1191483A/zh active Pending
- 1996-07-16 JP JP50646497A patent/JP2001503371A/ja active Pending
- 1996-07-16 IL IL12275196A patent/IL122751A0/xx unknown
- 1996-07-16 EA EA199800146A patent/EA199800146A1/ru unknown
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 EE EE9800020A patent/EE9800020A/xx unknown
- 1996-07-16 BR BR9610187A patent/BR9610187A/pt not_active Application Discontinuation
- 1996-07-16 MX MX9800603A patent/MX9800603A/es unknown
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/cs unknown
- 1996-07-16 SK SK32-98A patent/SK3298A3/sk unknown
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/ko not_active Withdrawn
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/xx unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/hr not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/sh unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/es unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127D0/no unknown
- 1998-01-14 BG BG102182A patent/BG102182A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK3298A3 (en) | 1998-07-08 |
| AU6367096A (en) | 1997-02-18 |
| CZ2798A3 (cs) | 1998-06-17 |
| NO980127L (no) | 1998-01-12 |
| WO1997003664A1 (en) | 1997-02-06 |
| EE9800020A (et) | 1998-08-17 |
| HU9502198D0 (en) | 1995-09-28 |
| AR002905A1 (es) | 1998-04-29 |
| BG102182A (bg) | 1998-08-31 |
| EP0841915A1 (en) | 1998-05-20 |
| PL324460A1 (en) | 1998-05-25 |
| CN1191483A (zh) | 1998-08-26 |
| CA2227421A1 (en) | 1997-02-06 |
| IL122751A0 (en) | 1998-08-16 |
| HRP960345A2 (en) | 1998-02-28 |
| JP2001503371A (ja) | 2001-03-13 |
| YU42796A (sh) | 1999-03-04 |
| ZA966079B (en) | 1998-01-19 |
| NO980127D0 (no) | 1998-01-12 |
| BR9610187A (pt) | 1998-07-28 |
| KR19990028933A (ko) | 1999-04-15 |
| WO1997003664A8 (en) | 1999-08-05 |
| EA199800146A1 (ru) | 1998-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| ES2145118T3 (es) | Derivados de acidos grasos y composiciones farmaceuticas que los contienen. | |
| ES2088312T3 (es) | Formulacion de liberacion controlada que contiene tramadol. | |
| ES2117015T3 (es) | Composiciones que contienen sumatriptan. | |
| BR0009893A (pt) | Composição de cuidado com a pele; e uso de uma composição de cuidado com a pele | |
| ES2163407T3 (es) | Derivados piperidinilos tiaciclicos. | |
| MX9307509A (es) | Metodo y preparacion farmaceutica para reducir la actividad de las celulas. | |
| MX17808A (es) | Nuevos derivados de artemisinina,procedimiento para su preparacion y su uso como agentes antiprosoos | |
| SE8001599L (sv) | Transdermalt medicineringssystem for isosorbiddinitrat | |
| CO4790100A1 (es) | Composicion cinergetica y metodos para tratar crecimientos neoplasicos o cancerosos y para restaurar o estimular hema- topoiesis | |
| ATE15596T1 (de) | Pharmazeutische mittel. | |
| TR199802769T2 (xx) | Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim. | |
| ES2084339T3 (es) | Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central. | |
| DK1383540T3 (da) | Fremgangsmdåer og farmaceutiske sammensætninger til sårheling | |
| ES2107035T3 (es) | Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc.. | |
| IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| ITMI922331A1 (it) | Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione | |
| ES2134237T3 (es) | Composiciones farmaceuticas que contienen acido ursodesoxicolico. | |
| ES2144154T3 (es) | Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica. | |
| ES2077559T3 (es) | Estabilizacion de proteinas terapeuticamente activas en preparados farmaceuticos. | |
| ES2145234T3 (es) | Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| FR2420344A1 (fr) | Nouveaux oxime-ethers, leur preparation et leur application therapeutique. | |
| DK0917460T3 (da) | Cyclosporin-formulering | |
| KR880007068A (ko) | 13-시스 레티노산의 용도 | |
| MX9800603A (es) | Uso de la ipriflavona para reducir el numero de celulas cd8+. |